Back to top
more

Franklin Biotechnology Discovery A: (MF: FBDIX)

(MF) As of Apr 26, 2017 06:05 PM ET

 Add to portfolio

$146.72 USD

+0.46 (0.32%)

Zacks MF Rank 1-Strong Buy 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Mar 31, 2017

Total Return %* Percentile Rank Objective
YTD 12.81 17
3 months 12.81 17
6 months 6.11 18
1 Year 23.79 7
3 Year 7.35 64
5 Year 19.64 7
10 Year 13.81 15

* Annual for three years and beyond.

Zacks Premium Research for FBDIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Strong Buy 1
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 24.92
% Yield 1.08
% SEC Yield NA
Net Assets (Mil $) 3/31/2017 1,200.48
%Turnover 3/31/2017 22.13

Risk

3 Year 5 Year 10 Year
Beta 1.64 1.37 0.86
Alpha -6.15 3.31 8.24
R Squared 0.42 0.33 0.36
Std. Dev. 26.13 24.34 22.23
Sharpe 0.42 0.95 2.00

Sector / Country Weightings

As of 3/31/2017 % of Portfolio
Health 66.04
Other 16.41
Services 14.65
Technology 2.26
Industrial Cyclical 0.33
Retail Trade 0.31

Portfolio Holdings

Top Equity Holdings
(As of 10/31/2016)
% of Portfolio Value (Mil$)
CELGENE CORP 9.80 119.30
BIOGEN INC 8.13 98.92
~TESARO INC 7.56 92.06
GILEAD SCIENCES INC 7.54 91.80
INCYTE PHARMACEUTICALS IN 4.82 58.73
AMGEN INC 4.50 54.78
REGENERON PHARMACEUTICALS 3.21 39.06
VERTEX PHARMACEUTICALS IN 3.03 36.85
ALEXION PHARMACEUTICALS I 2.80 34.14

Stock Holding % of Net Assets

As Of 10/31/2016
Total Issues 109
Avg. P/E 37.15
Avg. P/Book 6.16
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 31,577

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 33.68
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00